These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 26665557)
1. The expression and localization of estrogen receptor beta in hyperplastic and neoplastic prostate lesions. Levakov AF; Kaćanski MM; Vucković N; Zivojinov M; Amidzić J; Sabo JI Vojnosanit Pregl; 2015 Oct; 72(10):906-13. PubMed ID: 26665557 [TBL] [Abstract][Full Text] [Related]
2. Expression of estrogen receptor-B ( ER-B ) in bengin and malignant prostatic epithelial cells and its correlation with the clinico-pathological features. Gabal SM; Habib FM; Helmy DO; Ibrahim MF J Egypt Natl Canc Inst; 2007 Dec; 19(4):239-48. PubMed ID: 19672287 [TBL] [Abstract][Full Text] [Related]
3. The relation of beclin 1 and bcl-2 expressions in high grade prostatic intraepithelial neoplasia and prostate adenocarcinoma: a tissue microarray study. Baspinar S; Bircan S; Orhan H; Kapucuoglu N; Bozkurt KK Pathol Res Pract; 2014 Jul; 210(7):412-8. PubMed ID: 24690321 [TBL] [Abstract][Full Text] [Related]
4. Estrogen receptor beta expression in prostate adenocarcinoma. Asgari M; Morakabati A Diagn Pathol; 2011 Jul; 6():61. PubMed ID: 21733187 [TBL] [Abstract][Full Text] [Related]
5. Differential immunohistochemical expression of CD44s, E-cadherin and β-catenin among hyperplastic and neoplastic lesions of the prostate gland. Lazari P; Poulias H; Gakiopoulou H; Thomopoulou GH; Barbatis C; Lazaris AC Urol Int; 2013; 90(1):109-16. PubMed ID: 23220849 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma. Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228 [TBL] [Abstract][Full Text] [Related]
7. Apoptosis and nuclear shapes in benign prostate hyperplasia and prostate adenocarcinoma: comparison with and relation to Gleason score. Choi NG; Sohn JH; Park HW; Jung TY Int J Urol; 1999 Jan; 6(1):13-8. PubMed ID: 10221859 [TBL] [Abstract][Full Text] [Related]
8. Apoptosis incidence and protein expression of p53, TGF-beta receptor II, p27Kip1, and Smad4 in benign, premalignant, and malignant human prostate. Zeng L; Rowland RG; Lele SM; Kyprianou N Hum Pathol; 2004 Mar; 35(3):290-7. PubMed ID: 15017584 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of epithelial/stromal caveolin-1 expression in prostatic hyperplasia, high grade prostatic intraepithelial hyperplasia and prostatic carcinoma and its correlation with microvessel density. Mohammed DA; Helal DS J Egypt Natl Canc Inst; 2017 Mar; 29(1):25-31. PubMed ID: 28259631 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates. De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409 [TBL] [Abstract][Full Text] [Related]
11. Differentiation pathways and histogenetic aspects of normal and abnormal prostatic growth: a stem cell model. Bonkhoff H; Remberger K Prostate; 1996 Feb; 28(2):98-106. PubMed ID: 8604398 [TBL] [Abstract][Full Text] [Related]
13. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis. Parsons JK; Gage WR; Nelson WG; De Marzo AM Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556 [TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical localization of estrogen receptors in spontaneous and experimentally induced canine benign prostatic hyperplasia. Schulze H; Barrack ER Prostate; 1987; 11(2):145-62. PubMed ID: 2444954 [TBL] [Abstract][Full Text] [Related]
15. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. De Marzo AM; Meeker AK; Epstein JI; Coffey DS Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039 [TBL] [Abstract][Full Text] [Related]
16. Estrogen receptors alpha and beta in the normal, hyperplastic and carcinomatous human prostate. Royuela M; de Miguel MP; Bethencourt FR; Sánchez-Chapado M; Fraile B; Arenas MI; Paniagua R J Endocrinol; 2001 Mar; 168(3):447-54. PubMed ID: 11241176 [TBL] [Abstract][Full Text] [Related]
17. Downregulated gelsolin expression in hyperplastic and neoplastic lesions of the prostate. Lee HK; Driscoll D; Asch H; Asch B; Zhang PJ Prostate; 1999 Jun; 40(1):14-9. PubMed ID: 10344719 [TBL] [Abstract][Full Text] [Related]
18. Co-expression of TLR-9 and MMP-13 is associated with the degree of tumour differentiation in prostate cancer. Kalantari E; Abolhasani M; Roudi R; Farajollahi MM; Farhad S; Madjd Z; Askarian-Amiri S; Mohsenzadegan M Int J Exp Pathol; 2019 Apr; 100(2):123-132. PubMed ID: 31090157 [TBL] [Abstract][Full Text] [Related]
19. Expression of the VEGF-receptor Flt-1 in benign, premalignant and malignant prostate tissues. Hahn D; Simak R; Steiner GE; Handisurya A; Susani M; Marberger M J Urol; 2000 Aug; 164(2):506-10. PubMed ID: 10893635 [TBL] [Abstract][Full Text] [Related]
20. Expression of c-kit and kit-ligand in benign and malignant prostatic tissues. Simak R; Capodieci P; Cohen DW; Fair WR; Scher H; Melamed J; Drobnjak M; Heston WD; Stix U; Steiner G; Cordon-Cardo C Histol Histopathol; 2000 Apr; 15(2):365-74. PubMed ID: 10809354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]